Baxter International PE ratio BAX
Share price divided by earnings per share over the last twelve months, since 2010.
- Today, Oct 23, 2026
- n/m
- losses over the last year
- Last meaningful
- 169×
- Feb 2025
- 9-year median
- 36.3×
- 9-year range
- 16.7× to 169×
- Peer median
- 27.4×
Baxter International has no meaningful PE ratio today: it lost $2.08 a share over the last twelve months, and a PE needs earnings.
It was last meaningful in Feb 2025, at 169×.
On the days it had one over the last 9 years, its median was 36.3×, from 16.7× in May 2017 to 169× in Feb 2025.
PE ratio over time
The dashed line is the 9-year median and the shaded band the middle half of its days.
Year by year
| Year | End of year | Low | High |
|---|---|---|---|
| 2025 | 169× | 147× | 169× |
| 2024 | 146× | 146× | 169× |
| 2023 | n/m a value too high to mean anything | ||
| 2022 | 28.2× | 26.9× | 36.6× |
| 2021 | 35.9× | 31.9× | 46.4× |
| 2020 | 45.6× | 27.3× | 48.5× |
| 2019 | 28.3× | 24.8× | 33.2× |
| 2018 | 29.5× | 28.5× | 54.6× |
| 2017 | 34.8× | 16.7× | 39.8× |
| 2016 | 25.8× | 11.3× | 25.8× |
| 2015 | 12.2× | 8.0× | 12.3× |
| 2014 | 11.9× | 9.3× | 11.9× |
| 2013 | 9.6× | 8.7× | 10.0× |
| 2012 | 8.7× | 6.8× | 9.1× |
| 2011 | 7.1× | 6.9× | 12.9× |
| 2010 | 10.5× | 8.3× | 10.7× |
Against its peers
Companies in Medical - Instruments & Supplies nearest Baxter International's size, closest first, today.
| Company | PE ratio |
|---|---|
| BAXBaxter International | n/m |
| PENPenumbra | 79.7× |
| SOLVSolventum | 10.4× |
| COOCooper Companies | 20.9× |
| ALGNAlign Technology | 26.9× |
| GMEDGlobus Medical | 20.8× |
| PODDInsulet | 27.9× |
| MSAMSA Safety | 22.7× |
| WSTWest Pharmaceutical Services | 50.2× |
| MMSIMerit Medical Systems | 38.6× |
| HAEHaemonetics | 58.1× |
| Peer median | 27.4× |
What the PE ratio tells you
Share price divided by earnings per share over the last twelve months. It is the price tag on a dollar of profit: 20× means you pay $20 for $1 of yearly earnings.
Blank while earnings are negative. A very low PE can mean the market expects profits to fall, so read it with growth and the company's own history.
More on Baxter International
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.